SOLARA ACTIVE PHA SCI LTD (SOLARA) financials
SOLARA ACTIVE PHA SCI LTD (SOLARA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.[1]It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same tim…
- Market Cap: ₹3,381Cr.
- Current Price: ₹697
- Stock P/E: 68.6
- ROE: -0.11%
- ROCE: 4.91%
- Book Value: ₹297
- Dividend Yield: 0.00%
- 52W High / Low: ₹774/422
In Sep 2026, SOLARA ACTIVE PHA SCI LTD (SOLARA) reported sales ₹417 Cr and net profit ₹30 Cr.
Annual TTM: sales ₹1,535 Cr, net profit ₹39 Cr.
Shareholding: Promoters 41.93% (Jun 2026), FIIs 11.52% (Jun 2026), DIIs 3.74% (Jun 2026), Public 42.79% (Jun 2026), No. of Shareholders 70,490% (Jun 2026).
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 300 | 273 | 319 | 314 | 349 | 387 | 382 | 417 |
| Expenses | 243 | 230 | 262 | 279 | 312 | 330 | 320 | 340 |
| Operating Profit | 58 | 43 | 57 | 35 | 37 | 58 | 62 | 77 |
| OPM % | 19% | 16% | 18% | 11% | 11% | 15% | 16% | 18% |
| Other Income | 1 | 6 | 1 | 0 | -7 | 5 | 2 | -4 |
| Interest | 27 | 29 | 24 | 21 | 22 | 27 | 20 | 16 |
| Depreciation | 25 | 24 | 24 | 24 | 26 | 26 | 27 | 27 |
| Profit before tax | 8 | -5 | 11 | -10 | -17 | 10 | 17 | 30 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 8 | -5 | 11 | -10 | -17 | 10 | 17 | 30 |
| EPS in Rs | 2.25 | -1.35 | 2.91 | -2.79 | -4.82 | 2.69 | 3.52 | 6.10 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,322 | 1,617 | 1,268 | 1,444 | 1,289 | 1,284 | 1,369 | 1,535 |
| Expenses | 1,065 | 1,232 | 1,187 | 1,309 | 1,384 | 1,080 | 1,182 | 1,301 |
| Operating Profit | 257 | 385 | 81 | 134 | -95 | 204 | 187 | 234 |
| OPM % | 19% | 24% | 6% | 9% | -7% | 16% | 14% | 15% |
| Other Income | 27 | 28 | 14 | 22 | -184 | 9 | 0 | -4 |
| Interest | 78 | 84 | 75 | 90 | 106 | 115 | 94 | 86 |
| Depreciation | 94 | 108 | 112 | 111 | 103 | 99 | 100 | 105 |
| Profit before tax | 112 | 221 | -92 | -45 | -488 | -1 | -7 | 39 |
| Tax % | 0% | 0% | -36% | -50% | 16% | 0% | 0% | — |
| Net Profit | 112 | 221 | -59 | -22 | -567 | -1 | -7 | 39 |
| EPS in Rs | 31.42 | 46.13 | -12.20 | -4.63 | -118.10 | -0.30 | -2.00 | 7.49 |
| Dividend Payout % | 5% | 11% | 0% | -49% | 0% | 0% | 0% | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 36 | 36 | 36 | 36 | 40 | 45 | 48 |
| Reserves | 1,064 | 1,557 | 1,491 | 1,467 | 901 | 1,056 | 1,211 | 1,392 |
| Borrowings | 722 | 621 | 1,037 | 1,013 | 1,012 | 796 | 637 | 542 |
| Other Liabilities | 339 | 397 | 373 | 379 | 398 | 333 | 384 | 417 |
| Total Liabilities | 2,152 | 2,610 | 2,937 | 2,895 | 2,347 | 2,225 | 2,277 | 2,400 |
| Fixed Assets | 1,374 | 1,359 | 1,334 | 1,342 | 1,261 | 1,187 | 1,231 | 1,195 |
| CWIP | 40 | 88 | 239 | 238 | 256 | 280 | 205 | 208 |
| Investments | 18 | 18 | 15 | 16 | 14 | 2 | 2 | 2 |
| Other Assets | 719 | 1,145 | 1,350 | 1,298 | 815 | 757 | 839 | 996 |
| Total Assets | 2,152 | 2,610 | 2,937 | 2,895 | 2,347 | 2,225 | 2,277 | 2,400 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 166 | 242 | 154 | -242 | 156 | 111 | 213 | 153 |
| Cash from Investing Activity | -113 | -359 | -105 | -243 | -81 | -5 | -37 | -50 |
| Cash from Financing Activity | -23 | 97 | 92 | 334 | -113 | -107 | -180 | -103 |
| Net Cash Flow | 30 | -20 | 142 | -151 | -38 | -0 | -5 | 0 |
| Free Cash Flow | 107 | -26 | -16 | -451 | 46 | 69 | 173 | 101 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 84% | 103% | 49% | -276% | 106% | -116% | 105% | 83% |
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 37.27% | 37.23% | 37.94% | 42.01% | 42.01% | 42.00% | 42.00% | 41.93% |
| FIIs | 14.25% | 14.67% | 14.63% | 14.25% | 13.58% | 11.98% | 11.59% | 11.52% |
| DIIs | 3.37% | 3.19% | 2.61% | 2.62% | 2.69% | 3.64% | 3.75% | 3.74% |
| Public | 45.11% | 44.92% | 44.82% | 41.10% | 41.71% | 42.37% | 42.66% | 42.79% |
| No. of Shareholders | 71,882 | 83,148 | 75,791 | 74,334 | 72,479 | 71,890 | 70,400 | 70,490 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 76 | 63 | 109 | 141 | 136 | 99 | 93 | 117 |
| Inventory Days | 111 | 170 | 149 | 321 | 258 | 163 | 185 | 170 |
| Days Payable | 126 | 131 | 154 | 150 | 139 | 140 | 141 | 143 |
| Cash Conversion Cycle | 62 | 102 | 104 | 312 | 256 | 123 | 137 | 144 |
| Working Capital Days | -20 | -30 | 17 | 39 | 22 | -129 | -61 | -22 |
| ROCE % | 10% | 12% | 15% | -1% | 2% | -9% | 6% | 5% |
Solara Active Pha Sci Ltd
₹3,381Cr.
₹697
₹774/422
68.6
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.[1]It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company.[2]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of SOLARA ACTIVE PHA SCI LTD (SOLARA)?
The reported market capitalisation for SOLARA ACTIVE PHA SCI LTD (SOLARA) is ₹3,381Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of SOLARA?
The current price shown for SOLARA ACTIVE PHA SCI LTD (SOLARA) on Fincrux is ₹697 with a 52-week high/low of ₹774/422.
What is the P/E ratio of SOLARA ACTIVE PHA SCI LTD (SOLARA)?
The stock P/E for SOLARA ACTIVE PHA SCI LTD (SOLARA) is 68.6 on Fincrux, with ROE at -0.11% and ROCE at 4.91%.
What were SOLARA latest quarterly results?
For Sep 2026, SOLARA ACTIVE PHA SCI LTD (SOLARA) reported sales ₹417 Cr and net profit ₹30 Cr (figures in ₹ crore unless noted).
What are SOLARA annual sales and net profit?
For TTM, SOLARA ACTIVE PHA SCI LTD (SOLARA) shows sales of ₹1,535 Cr and net profit of ₹39 Cr on the Fincrux profit & loss statement.
Who owns SOLARA ACTIVE PHA SCI LTD (SOLARA)?
Latest shareholding for SOLARA ACTIVE PHA SCI LTD (SOLARA) on Fincrux: Promoters 41.93% (Jun 2026), FIIs 11.52% (Jun 2026), DIIs 3.74% (Jun 2026), Public 42.79% (Jun 2026), No. of Shareholders 70,490% (Jun 2026).
Where can I find SOLARA ACTIVE PHA SCI LTD (SOLARA) financials?
SOLARA ACTIVE PHA SCI LTD (SOLARA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show SOLARA balance sheet and cash flow?
Yes. The SOLARA ACTIVE PHA SCI LTD (SOLARA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.